BlackRock’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$532M Sell
9,630,341
-106,426
-1% -$5.88M 0.01% 1012
2025
Q1
$471M Sell
9,736,767
-147,850
-1% -$7.15M 0.01% 1084
2024
Q4
$382M Sell
9,884,617
-339,678
-3% -$13.1M 0.01% 1254
2024
Q3
$460M Buy
10,224,295
+4,466,183
+78% +$201M 0.01% 1136
2024
Q2
$200M Buy
5,758,112
+188,627
+3% +$6.54M ﹤0.01% 1615
2024
Q1
$161M Buy
5,569,485
+25,583
+0.5% +$740K ﹤0.01% 1764
2023
Q4
$127M Buy
5,543,902
+314,477
+6% +$7.21M ﹤0.01% 1919
2023
Q3
$87.2M Buy
5,229,425
+220,152
+4% +$3.67M ﹤0.01% 2046
2023
Q2
$138M Buy
5,009,273
+607,056
+14% +$16.8M ﹤0.01% 1816
2023
Q1
$101M Buy
4,402,217
+750,060
+21% +$17.3M ﹤0.01% 1990
2022
Q4
$39.8M Buy
3,652,157
+189,773
+5% +$2.07M ﹤0.01% 2588
2022
Q3
$29.2M Buy
3,462,384
+7,468
+0.2% +$63K ﹤0.01% 2786
2022
Q2
$27.3M Buy
3,454,916
+208,742
+6% +$1.65M ﹤0.01% 2855
2022
Q1
$76.9M Sell
3,246,174
-35,462
-1% -$840K ﹤0.01% 2280
2021
Q4
$112M Buy
3,281,636
+82,140
+3% +$2.81M ﹤0.01% 2129
2021
Q3
$56.7M Buy
3,199,496
+158,955
+5% +$2.82M ﹤0.01% 2557
2021
Q2
$136M Buy
3,040,541
+38,912
+1% +$1.75M ﹤0.01% 2043
2021
Q1
$77.7M Buy
3,001,629
+409,918
+16% +$10.6M ﹤0.01% 2312
2020
Q4
$52.2M Buy
2,591,711
+135,734
+6% +$2.74M ﹤0.01% 2396
2020
Q3
$48M Buy
2,455,977
+414,517
+20% +$8.1M ﹤0.01% 2283
2020
Q2
$36.1M Buy
2,041,460
+484,004
+31% +$8.55M ﹤0.01% 2409
2020
Q1
$11M Sell
1,557,456
-4,501
-0.3% -$31.8K ﹤0.01% 2900
2019
Q4
$11M Buy
1,561,957
+478,755
+44% +$3.38M ﹤0.01% 3158
2019
Q3
$13M Buy
1,083,202
+65,781
+6% +$790K ﹤0.01% 3044
2019
Q2
$12.3M Buy
1,017,421
+743,632
+272% +$9.01M ﹤0.01% 3100
2019
Q1
$3.44M Buy
273,789
+13,241
+5% +$166K ﹤0.01% 3504
2018
Q4
$1.75M Buy
260,548
+21,126
+9% +$142K ﹤0.01% 3692
2018
Q3
$2.46M Sell
239,422
-14,613
-6% -$150K ﹤0.01% 3647
2018
Q2
$1.71M Sell
254,035
-433,125
-63% -$2.91M ﹤0.01% 3740
2018
Q1
$5.9M Buy
687,160
+192,632
+39% +$1.66M ﹤0.01% 3334
2017
Q4
$10.3M Buy
494,528
+47,003
+11% +$978K ﹤0.01% 3101
2017
Q3
$7.91M Buy
447,525
+16,059
+4% +$284K ﹤0.01% 3251
2017
Q2
$4.88M Buy
431,466
+85,821
+25% +$970K ﹤0.01% 3433
2017
Q1
$4.43M Buy
345,645
+345,383
+131,826% +$4.42M ﹤0.01% 3382
2016
Q4
$6K Buy
+262
New +$6K ﹤0.01% 3439